Delayed dosing intervals for quadrivalent human papillomavirus vaccine do not reduce antibody avidity

.
Source: Human Vaccines and Immunotherapeutics - Category: Allergy & Immunology Authors: Source Type: research

Related Links:

Condition:   Dengue Fever Interventions:   Biological: 9vHPV vaccine;   Biological: Dengue Tetravalent Vaccine (TDV) Sponsor:   Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Source: CDC Preventing Chronic Disease - Category: International Medicine & Public Health Tags: Public Health Source Type: news
Conditions:   HIV Infections;   HPV Infection Intervention:   Biological: Human Papillomavirus 9-valent Vaccine, Recombinant Sponsors:   University Hospital Virgen de las Nieves;   Instituto de Salud Carlos III Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy & Immunology | Cervical Cancer Vaccine | Gardasil | Genital Warts | Human Papillomavirus (HPV) | Vaccines